English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Important notice
Current portfolio
VarmX
Dutch biotech company developing an innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants.
Sector
Healthcare
Country
Netherlands
Fund
LSP 6
Entry
2020
Web
varmx.com
Sector
Healthcare
Country
Netherlands
Fund
LSP 6
Entry
2020
Web
varmx.com
0
Investments
EQT logo